Co-promotion agreement for MassARRAY DX clinical diagnostics technologyCo-Promotion Agreement • July 3rd, 2024
Contract Type FiledJuly 3rd, 2024Agena Bioscience announced a co-promotion agreement leveraging its MassARRAY DX clinical diagnostics technology with HeartGenetics' CE-IVD marked products for cardiovascular testing.